News
NRG Therapeutics gains further funding from Parkinson’s UK
Cambridge-based biotech company NRG Therapeutics has received further funding of £490k from Parkinson’s UK, bringing the total amount invested by the charity to £2.5m.
You're using an outdated browser. To get the most out of this website, as well as many others, please consider upgrading to a modern browser, such as Google Chrome, Mozilla Firefox, or Microsoft Edge.
Cambridge-based biotech company NRG Therapeutics has received further funding of £490k from Parkinson’s UK, bringing the total amount invested by the charity to £2.5m.